Tumor Dosimetry And Radiobiological Study For High-Activity 131I-mIBG Therapy In The Management Of Refractory/Relapsed Neuroblastoma

被引：0
|
作者：
Polito, C. [1 ]
Cassano, B. [1 ]
Genovese, E. [1 ]
Longo, M. [2 ]
Donatiello, S. [1 ]
Insero, T. [1 ]
Valeri, S. [1 ]
Villani, M. F. [1 ]
Castellano, A. [1 ]
Garganese, M. C. [1 ]
Cannata, V. [1 ]
机构：
[1] IRCCS Bambino Gesu Childrens Hosp, Rome, Italy
[2] Arcispedale St Anna Hosp, Ferrara, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0221
引用
下载
收藏
页码：S484 / S484
页数：1
相关论文
共 50 条
  • [31] Phase II study of 131I-MIBG with vincristine and 5 days of irinotecan for patients with relapsed or refractory neuroblastoma.
    DuBois, Steven G.
    Allen, M. Shelly
    Bent, Melissa
    Hilton, Joan
    Hollinger, Fabienne
    Courtier, Jesse
    Hawkins, Randall
    Mosse, Yael P.
    Matthay, Katherine K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] The Optimal Use And Effectiveness Of131I-meta Iodobenzylguanidine (131I-mIBG) Molecular Radiotherapy For High-Risk And Relapsed/Refractory Neuroblastoma
    Plaza de las Heras, I.
    Osuna Marco, M.
    Martin Lopez, L.
    Villa Alcazar, M.
    Field Galan, C.
    Garcia Canamaque, L.
    Lopez Ibor, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S348 - S348
  • [33] THE OPTIMAL USE AND EFFECTIVENESS OF 131I-META IODOBENZYLGUANIDINE (131I-MIBG) MOLECULAR RADIOTHERAPY FOR HIGH-RISK AND RELAPSED/REFRACTORY NEUROBLASTOMA
    Marco, Marta Osuna
    Lopez, Laura Martin
    Plaza De las Heras, Isabel
    Alcazar, Marta Villa
    Lopez-Ibor, Blanca
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S226 - S226
  • [34] Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
    Buckley, Susan E.
    Chittenden, Sarah J.
    Saran, Frank H.
    Meller, Simon T.
    Flux, Glenn D.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (09) : 1518 - 1524
  • [35] High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience
    Hiroshi Wakabayashi
    Daiki Kayano
    Anri Inaki
    Raita Araki
    Rie Kuroda
    Yasuhiro Ikawa
    Toshihiro Fujiki
    Norihito Akatani
    Takafumi Yamase
    Satoru Watanabe
    Tomo Hiromasa
    Yuji Kunita
    Hiroshi Mori
    Shintaro Saito
    Ryosei Nishimura
    Taizo Wada
    Seigo Kinuya
    Annals of Nuclear Medicine, 2020, 34 : 840 - 846
  • [36] Dosimetry-Based Tandem High-Dose 131I-MIBG Therapy For Paediatric Patients With High Risk Neuroblastoma
    Longo, M.
    Cassano, B.
    Genovese, E.
    Donatiello, S.
    Villani, M.
    Pizzoferro, M.
    Garganese, M.
    Serra, A.
    Castellano, A.
    Cannata, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S224 - S225
  • [37] Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy 123I-MIBG Versus Posttherapy 131I-MIBG Imaging
    Pandit-Taskar, Neeta
    Zanzonico, Pat
    Hilden, Patrick
    Ostrovnaya, Irina
    Carrasquillo, Jorge A.
    Modak, Shakeel
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : 741 - 748
  • [38] 131I-MIBG therapy: Dosimetry estimations in neuroendocrine patients.
    Castellani, M. R.
    Chiesa, C.
    Luksch, R.
    Aliberti, A.
    Maccauro, M.
    Seregni, E.
    Bombardieri, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S317 - S317
  • [39] Modulation of Radiation Biomarkers in a Randomized Phase II Study of 131I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma
    Campbell, Kevin
    Groshen, Susan
    Evans, Angela C.
    Wilson, Stephen
    Sebastian, Aimy
    Loots, Gabriela G.
    Marachelian, Araz
    Armant, Myriam
    Pal, Sharmistha
    Haas-Kogan, Daphne A.
    Park, Julie R.
    Granger, Meaghan
    Matthay, Katherine K.
    Coleman, Matthew A.
    DuBois, Steven G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (05): : 1115 - 1128
  • [40] Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131I-MIBG in patients with relapsed/refractory neuroblastoma
    Batra, Vandana
    Gikandi, Ajami
    Pawel, Bruce
    Martinez, Daniel
    Granger, M. Meaghan
    Marachelian, Araz
    Park, Julie R.
    Maris, John M.
    Vo, Kieuhoa T.
    Matthay, Katherine K.
    DuBois, Steven G.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (01)
12345